12 October – World Arthritis Day

On World Arthritis Day, Astrapharm, as a national manufacturer of non-steroidal anti-inflammatory drugs, aims to:

1 – raise awareness of rheumatological diseases among Ukrainians

Arthritis is an inflammation of one or more joints accompanied by pain, fever, stiffness, swelling, and limited mobility in the affected joints.

– It affects more than 350 million people worldwide;
– includes more than 100 types of the disease and related conditions that affect not only joints but other organs as well;
– is considered one of the leading causes of disability in the country.

2 – outline the main risk factors for developing arthritis

Trauma, metabolic disorders, genetic predisposition (predominantly female), infections, and immune system dysfunction are the most common causes of the disease.

3 – Recall the importance of prevention and timely treatment

Although arthritis cannot be completely prevented, it can be controlled with medication and healthy lifestyle habits:

– maintain normal body weight;
– maintain a balanced diet;
– keep blood sugar levels under control;
– exercise;
– Avoid injuries.

For the prevention and treatment of arthritis, the pharmaceutical company Astrapharm produces:

– Non-steroidal anti-inflammatory drugs: Melsi (meloxicam), Ketodex (dexketoprofen trometamol) and Nimelgan (nimesulide);
– Chondroprotectors: Chitart in oral and injectable form.

Astrapharm – the art of helping people!